Hypertensive Pregnancy Disorders and Subsequent Cardiovascular Morbidity and Type 2 Diabetes Mellitus in the Mother
By J. Lykke, J. Langhoff‐Roos, B. Sibai, E. Funai, E. Triche, M. Paidas. HYPERTENSION, 2009
653 citations recorded by the source corpus.
Subfields: Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health
View Paper: https://www.semanticscholar.org/paper/4f07575c6836244d7bde6ffda28fd81c1cff8a17
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pediatrics, Perinatology and Child Health
Citations in the corpus
- Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis (2013, methodology): “Three articles reported CVD outcomes for women who had pre-eclampsia and delivered pre-term relative to those who had pre-eclampsia only [26, 41, 42].”
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2017, neutral): “5 [194, 195], while the RR of developing hypertension is ~3 [196] and DM ~2 [194, 197].”
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice. (2016, background): “5,(194,195) while the RR of developing hypertension is 3(196) and DM 2.(194,197) Because most studies did not adjust the elevated risk of future CVD for the development of convention-”
- The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. (2018, background): “higher the earlier the presentation (31); to date, no tests have reliably predicted which women with gestational hypertension will later develop pre-eclampsia(32) o Gestational hypertension, like pre-eclampsia, is also associated with cardiovascular disease in the long-term (33-36).”
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice (2016, background): “5,(194,195) while the RR of developing hypertension is 3(196) and DM 2.(194,197) Because most studies did not adjust the elevated risk of future CVD for the development of convention-”